News und Analysen
Today’s market could make Sysco stock break out, will it?
The new market cycle is getting underway, and some investors – maybe even yourself – are getting carried away by the bullish media and the market’s all-time high prices today. Far from sounding
Industrial's building a base for upward momentum
The overall market continues to trade at all-time highs, with the SPDR S&P 500 ETF Trust (NYSE: SPY) already up an impressive 2.5% year-to-date and over 16% during the previous three months. The
Hess stock to see 96% growth in EPS
The markets may have just ended their super cycle for the past four years (2020-2024), sponsored by low-interest rate environments pushed by the FED to counteract the effects of the COVID-19
Could Rumble’s video platform reach its tipping point in 2024?
Video-sharing platform Rumble Inc. (NASDAQ: RUM) shares surged over 60% in a week, driven by several catalysts. Perhaps more importantly, it's caught the attention of traders and investors.
2 undisputed chip leaders that each owns a 90% market share
Commanding 80% or more market share in any industry segment is a worthy feat, especially on a global scale in the computer and technology sector. They say the lion on top of the mountain is not as
Marriott International is the juggernaut that keeps growing
Leading global hospitality giant Marriott International Inc. (NASDAQ: MAR) stock continues to make new all-time highs as the travel boom continues to rebound. Unlike most industries facing
SoFi stock to have huge earnings growth, markets like the story
Many market participants have become weary of the new all-time highs being pushed out by the market indices, such as the broader S&P 500 or the technology-heavy NASDAQ. The law of the market stood
Eilt: Sensationelle Studienergebnisse - Hautkrebs vollständig geheilt. Massives Kaufsignal. Neuer 224% Biotech Hot Stock nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB)
Eilt: Sensationelle Studienergebnisse - Hautkrebs vollständig geheilt. 192% Biotech Hot Stock nach 134.452% mit Biogen
29.01.24 08:02
London (www.aktiencheck.de , Anzeige)
What makes Textron a must-own aerospace stock for 2024?
A 9% jump during Wednesday's session made Textron Inc. (NYSE: TXT) one of the best-performing equities on the market. This latest jump in share price for the Rhode Island-based aerospace company
Is Nike consolidating before a fresh rally?
For a stock that could do nothing wrong for a long time, it's been a tough couple of months for Nike Inc. (NYSE: NKE). A dodgy earnings report last month, including the dreaded weak forward
3 well-known consumer cyclical stocks offering 5% dividends
Lately, the major domestic stock indices are getting into a habit of setting fresh all-time highs.
Unwavering hopes of aggressive Federal Reserve interest rate cuts in 2024 have pushed the Dow
3 large caps near 52-week lows with large dividends
How fitting that Thursday night’s full moon was also referred to as the ‘wolf moon.’
U.S. stock indices howled to fresh all-time highs this week as the first full moon of 2024 lit up the evening
Discover leads financial stocks higher, but is trouble lurking?
Bank stocks and other financials tracked in the Financial Select Sector SPDR Fund (NYSEARCA: XLF) are rallying to two-year highs, with Discover Financial Services (NYSE: DFS) among the leaders.
Eilt: Hautkrebs vollständig geheilt - Institutionelle Investoren vor Einstieg. Massives Kaufsignal. Neuer 224% Biotech Aktientip nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB)
Eilt: Hautkrebs vollständig geheilt - Institutionelle Investoren vor Einstieg. Neuer 192% Biotech Aktientip nach 15.973%
26.01.24 08:02
London (www.aktiencheck.de, Anzeige)
Abbott Laboratories on track for new highs in 2024
Abbott Laboratories (NYSE: ABT) share price fell following its Q4 2023 results, but investors should be cheering the news. The decline is a response to a report that was largely as expected, with
This one wireless service stock could blow past earnings
Now that the Federal Reserve (the Fed) has pivoted its strategy to the opposite end of where it had been throughout 2023, meaning they are now proposing to cut interest rates after an aggressive
Verizon and AT&T: One is a high-yield value, the other a trap
Verizon Communications Inc. (NYSE: VZ) and AT&T Inc. (NYSE: T) have presented value and yield to investors for years.
However, they failed to sustain interest in their stocks, creating a drag on
These 5 growth stocks are now in buy ranges
Chart patterns and consolidations are worth watching, as they provide actionable guidance for making a purchase.
With the recent uptrend in large-cap stocks, as reflected by the performance of
Eilt: Durchbruch in Krebstherapie - Institutionelle Investoren vor Einstieg. Massives Kaufsignal. Neuer 224% Biotech Hot Stock nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB)
Eilt: Durchbruch in Krebstherapie - Institutionelle Investoren vor Einstieg. Neuer 224% Biotech Hot Stock nach 134.452%
25.01.24 08:03
London (www.aktiencheck.de , Anzeige)
Food fight! Which grocery store stocks will win in 2024?
Food distributors and retailers are living up to their reputation as the best consumer staples industry to own.
Up 2.1% year-to-date, the group has a sizable early lead over its roughly flat sec
5 top healthcare stocks for earnings growth in 2024
While the healthcare sector delivered lackluster profit growth in 2023, it should change this year.
Sector components forecast to show the biggest earnings year-over-year earnings improvement
Why Apple’s about to smash through $200 and continue
Microsoft Corporation (NASDAQ: MSFT) recently overtook Apple Inc. (NASDAQ: AAPL) as the world's most valuable company while also setting its all-time high; expectations are high for Apple to make
Will leverage and pricing power drive Netflix to a record high?
The Netflix Inc. (NASDAQ: NFLX) narrative is not without risk. The company struggled with growth following the COVID-19 bubble, but those days are behind. The story today is leverage, driven by
Eilt: Institutionelle Investoren begeistert von innovativer Krebstherapie. Massives Kaufsignal. Neuer 199% Biotech Aktientip nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB)
Eilt: Großinvestoren begeistert von innovativer Krebstherapie. Neuer 199% Biotech Aktientip nach 15.973% mit BioNTech
24.01.24
London (www.aktiencheck.de, Anzeige)
Link
3 reasons to buy Meta stock ahead of earnings
Meta Inc (NASDAQ: META) reports Thursday of next week in what will be one of the more closely watched reports of the year so far. The tech giant ended 2023 on a high, and its rally has, for the